Treatment of Complicated Staphylococcus aureus Bacteremia

Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS randomized clinical trial and more with JAMA Deputy Editor Preeti Malani, MD, MSJ. Related Content: Dalbavancin for Treatment of Staphylococcus aureus Bacteremia Management of Staphylococcus aureus Bacteremia

You can listen to Treatment of Complicated Staphylococcus aureus Bacteremia online on Radio and Podcast. Open the player on this page to stream the available audio.

Treatment of Complicated Staphylococcus aureus Bacteremia is an episode from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. by American Medical Association.

This episode is 11:35 long.

This episode was published on Aug 13, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. when more episodes are available from the podcast feed.